Therapeutics News

Researchers found genetic differences in hereditary palmoplantar keratoderma subtypes, indicating that genetic testing may be a valuable tool in accurately diagnosing the disease, according to a study.

The dermatology space has seen many FDA approvals and expansions in 2024.

An in-depth interview about the effects of the CMS’s 2025 physician fee schedule on patient access topped Healio Dermatology’s most-read articles of November, with FDA news also garnering attention.

The CMS finalized cuts to the 2025 physician fee schedule for the fifth year in a row, prompting an urgent call-to-action from the American Academy of Dermatology. HHS, through the CMS, announced the finalization of the 2025 Medicare Physician Fee Schedule.

ORLANDO — Patients with rosacea experienced an improvement in symptoms following cryomodulation, according to pilot study results presented at the American Society for Dermatologic Surgery Annual Meeting.

The FDA has approved Botox Cosmetic to temporarily improve the appearance of moderate to severe platysma bands — vertical bands that connect the jaw and neck — in adults, according to a press release from the manufacturer.

ORLANDO — Autologous skin cell suspension using RECELL was an effective and safe treatment for patients with stable vitiligo, according to a presentation at the American Society for Dermatologic Surgery Annual Meeting.

ORLANDO — A speaker at the American Society for Dermatologic Surgery Annual Meeting highlighted a set of international consensus recommendations for the use of energy-based devices for acne scar treatment.

Organon and Dermavant have entered a definitive agreement in which Organon will acquire Dermavant, according to a press release.